maintenance therapy

Type: Keyphrase
Name: maintenance therapy
First reported Apr 17 2014 - Updated Apr 17 2014 - 1 reports

Maintenance Therapy for Colorectal Cancer

Maintenance therapy has become quite a hot topic for those of us working in the field of solid tumor malignancies. Our original concept of chemotherapy for solid tumors was to give a certain number of cycles and then stop treatment, or to continue treatment ... [Published Cancernetwork.com - Apr 17 2014]
First reported Apr 15 2014 - Updated Apr 15 2014 - 1 reports

Consolidation with arsenic trioxide averted maintenance therapy in APL

Treatment with arsenic trioxide during consolidation may obviate the need for maintenance therapy in patients with previously untreated low- and intermediate-risk acute promyelocytic leukemia , according to study results.In a noninferiority trial, researchers ... [Published Orthopedics Today - Apr 15 2014]
First reported Apr 09 2014 - Updated Apr 09 2014 - 2 reports

Innovative new therapy offers new hope for paraplegics

neurostimulator used for the study is made by Medtronic , a medical technology company, and is currently is available as a maintenance therapy to individuals with chronic back ... ... [Published Big News Network - Apr 09 2014]
First reported Apr 04 2014 - Updated Apr 04 2014 - 1 reports

Resected Pancreatic Cancer: Why Wait for the Inevitable?

Hello, everybody. This is John Marshall for Medscape.There is a lot going on in the area that we call "maintenance therapy." We are showing that, with solid tumors in particular, if you keep some treatment going, then patients actually have a delayed ... [Published Diabetes Care - Apr 04 2014]
First reported Apr 04 2014 - Updated Apr 04 2014 - 1 reports

Home-delivery detox GP fined $10k

A GP who treated heroin addicts using rapid opioid detoxification in their homes and hotel rooms, after only "cursory" examinations, has been reprimanded and fined $10,000.Dr Zeitoun Athour, a 56-year-old IMG from Turkey, treated 14 patients in 2010 using ... [Published Australian Doctor - Apr 04 2014]
First reported Apr 02 2014 - Updated Apr 02 2014 - 1 reports

Medicare updates reimbursement criteria for “maintenance” therapy services

A Quiet “Sea Change” in Medicare (The New York Times): “In January, Medicare officials updated the agency’s policy manual –the rule book for everything Medicare does– to erase any notion that improvement is necessary to receive coverage for skilled ... [Published SharpBrains - Apr 02 2014]
First reported Mar 31 2014 - Updated Apr 01 2014 - 1 reports

Regulatory update Votrient pazopanib as maintenance therapy for advanced ovarian cancer in the EU

Related Biotechnology, Pharmaceutical and Healthcare NewsGlaxoSmithKline plc (LSE/NYSE: GSK) today announced that it has withdrawn its application to the European Medicines Agency (EMA) for a variation to the Marketing Authorisation for Votrient® (pa ... [Published BioPortfolio - Mar 31 2014]
First reported Mar 28 2014 - Updated Mar 28 2014 - 1 reports

My View: Fighting heroin will take the whole community

Thank You. My letter begins with a thank you to our local law enforcement agencies, paramedics, fire departments, politicians, criminal justice system, coroner’s office, families and the editorial staff at The Rockford Register Star for all that you have ... [Published Rockford Register Star - Mar 28 2014]
First reported Mar 28 2014 - Updated Mar 28 2014 - 1 reports

Maintenance Therapy With the PARP Inhibitor Olaparib Significantly Improves PFS in Ovarian Cancer

Patients randomized to olaparib had a 60% improvement in the exploratory endpoint of time to first subsequent therapy or death (TFST) as compared with placebo-treated patients, according to Ursula Matulonis, MD,  of the Dana-Farber Cancer Institute in ... [Published American Journal of Managed Care - Mar 28 2014]
First reported Mar 26 2014 - Updated Mar 27 2014 - 2 reports

AntiPARP Tx Works in Advanced Ovarian Cancer

Related Biotechnology, Pharmaceutical and Healthcare NewsTAMPA, Fla. (MedPage Today) -- Advanced ovarian cancer treated with PARP inhibitor maintenance therapy had significant improvement in progression-free survival, extending beyond first progression, ... [Published BioPortfolio - Mar 27 2014]
First reported Mar 24 2014 - Updated Mar 24 2014 - 1 reports

Rituximab May Ease Anxiety in Follicular Lymphoma Patients

Reuters Health InformationBy Frederik JoelvingMarch 24, 2014NEW YORK (Reuters Health) - Rituximab maintenance therapy may lessen cancer-related anxiety compared with watchful waiting in asymptomatic patients with advanced-stage non-bulky follicular lymphoma, ... [Published Diabetes Care - Mar 24 2014]
First reported Mar 23 2014 - Updated Mar 23 2014 - 1 reports

Forum Post: Re: paul

Hi Paul, As you say rare illness. I was diagnosed this time last year and no serious clinical symptoms - discovered while investigating a lump. However I was immediately put on 6 cycles of R-CHOP, 6 weeks apart. Since then I have been on 8 weekly cycles ... [Published Macmillan Cancer Support - Mar 23 2014]

Quotes

...Greciet, CEO at BioAlliance and future leader of the combined company, called the merger "atypical," but thinks it works well for both parties. "It will make us bigger and stronger in negotiations and in the search for partnerships in different territories worldwide" Greciet told the media on a call attended by Bloomberg . Both companies have retained the rights to their pipeline products in Europe...
"Positive momentum is building and Baxter is off to a strong start in 2014," said Robert L Parkinson, Jr., chairman and chief executive officer. "We delivered strong financial results, continued to enhance our flexibility to invest for future growth, build and advance the new product pipeline, expand our business portfolios and position the company for sustained performance and success."
According to the news editors, the research concluded: "This article describes a patient with refractory ALK(+) anaplastic large cell lymphoma who experienced a complete response to the ALK inhibitor crizotinib and then underwent an allogeneic stem cell transplant followed by crizotinib maintenance therapy."
...is a partial agonist with a more favorable safety profile and less abuse potential than full agonists such as methadone," explains Sigmon. "There is also greater regulatory flexibility associated with buprenorphine, which will permit us to provide the medication without the rigid restrictions in place for methadone."

More Content

All (113) | News (104) | Reports (0) | Blogs (9) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
The Efficacy of Anti-TNF Agents for Ulcerative ... [Published Diabetes Care - Apr 18 2014]
Nasdaq volatility delays IPO, Almirall pulls dr... [Published FierceBiotech - Apr 18 2014]
Baxter International's CEO Discusses Q1 2014 Re... [Published Seeking Alpha - Apr 17 2014]
Baxter Reports Strong First Quarter Financial R... [Published BusinessWeek - Apr 17 2014]
Maintenance Therapy for Colorectal Cancer [Published Cancernetwork.com - Apr 17 2014]
Drug treatment nonsense: Science first ― Fifa R... [Published Malay Mail - Apr 17 2014]
Study Results from Harvard University Provide N... [Published HispanicBusiness.com - Apr 17 2014]
Treatment Landscape for Mantle Cell Lymphoma Co... [Published OncLive - Apr 16 2014]
Cancer Risk With Adalimumab in Crohn's Disease [Published General Medicine eJournal - Apr 16 2014]
An overview of phototherapy for psoriasis [Published The Clinical Advisor - Apr 15 2014]
Consolidation with arsenic trioxide averted mai... [Published Orthopedics Today - Apr 15 2014]
The CoMMpass Trial in Multiple Myeloma [Published The ASCO Post - Apr 15 2014]
New therapy for managing moderate to severe chr... [Published Canadian Family Physician - Apr 15 2014]
Researcher develops novel IBT to help opioid-de... [Published News-Medical.Net - Apr 11 2014]
Study addresses treatments for waited-listed op... [Published Medical Xpress - Apr 10 2014]
New edition of RADAR includes review of glycopy... [Published News-Medical.Net - Apr 10 2014]
High-Risk Myeloma: Maintenance Pros & Cons [Published Oncology Times - Apr 10 2014]
Innovative new therapy offers new hope for para... [Published Big News Network - Apr 09 2014]
Innovative new therapy offers new hope for parp... [Published WHP CBS21 - Apr 09 2014]
Innovative new therapy offers new hope for para... [Published CBS News - Apr 09 2014]
Ambit initiates QUANTUM-R Phase 3 clinical tria... [Published News-Medical.Net - Apr 08 2014]
Kamada Joins U.S. Proof-of-Concept Study with G... [Published Individual.com - Apr 08 2014]
Aspirin may prevent preeclampsia in pregnant women [Published CBS News - Apr 08 2014]
Resected Pancreatic Cancer: Why Wait for the In... [Published Diabetes Care - Apr 04 2014]
Data on Cystic Fibrosis Reported by Researchers... [Published NewsRX - Apr 04 2014]
Home-delivery detox GP fined $10k [Published Australian Doctor - Apr 04 2014]
Ascites predicts bevacizumab benefit in advance... [Published Oncology Report - Apr 04 2014]
From Patient to President of the Hepatitis C As... [Published EverydayHealth.com - Apr 03 2014]
Study Results from Catholic University of Leuve... [Published HispanicBusiness.com - Apr 02 2014]
Titan & Braeburn Prep Next Steps With Probuphine [Published Yahoo! Finance - Apr 02 2014]
1 2 3 4
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Medicare updates reimbursement criteria for “ma... [Published SharpBrains - Apr 02 2014]
A Quiet “Sea Change” in Medicare (The New York Times): “In January, Medicare officials updated the agency’s policy manual –the rule book for everything Medicare does– to erase any notion that improvement is necessary to receive coverage for skilled ...
Anti-PARP Tx Works in Advanced Ovarian Cancer [Published MedPageToday.com - medical news plus CME for ph ... - Mar 26 2014]
TAMPA, Fla. (MedPage Today) -- Advanced ovarian cancer treated with PARP inhibitor maintenance therapy had significant improvement in progression-free survival, extending beyond first progression, investigators reported. ...
Vedolizumab as Induction and Maintenance Therap... [Published NEJM Most Cited Articles - Recent - Feb 01 2014]
Vedolizumab as Induction and Maintenance Therap... [Published NEJM Most Cited Articles - Recent - Feb 01 2014]
Clinic Speak: pregnancy risks and fingolimod [Published Multiple Sclerosis Research - Jan 30 2014]
Did you know highly-effective DMTs increase your chances of falling pregnant? Why? #ClinicSpeak #MSBlog #MSResearch "I have been saying for sometime that we should consider rebranding MS a pink-ribbon disease. MS is a disease of young woman of child-bearing ...
1 2
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.